6 biotech stocks for a volatile bull market: Jon Erlichman
BNN Bloomberg · Jon Erlichman ·
Biotech stocks can be volatile, even in a bull market. So how do investors avoid the traps?
Biotech stocks can be volatile, even in a bull market. So how do investors avoid the traps?
We asked Eden Rahim of Next Edge Capital, who has had plenty of success investing in biotech. He estimates roughly 40 of the companies he’s invested in over the years have been acquired, including three companies he highlighted on Ticker Take last year.
His game plan is to own companies that are far along in drug development, where the biggest risks are behind them.
Read the full story at BNN Bloomberg · All coverage of this story